Skip to main content

and
  1. Article

    Open Access

    The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity

    Despite the recent clinical success of T cell checkpoint inhibition targeting the CTLA-4 and PD-1 pathways, many patients either fail to achieve objective responses or they develop resistance to therapy. In so...

    Mark F. Maurer, Katherine E. Lewis, Joseph L. Kuijper in Nature Communications (2022)

  2. Article

    Open Access

    Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models

    Uncontrolled immune response with T cell activation has a key role in the pathogenesis of systemic sclerosis (SSc), a disorder that is characterized by generalized fibrosis affecting particularly the lungs and...

    Cindy Orvain, Anne Cauvet, Alexis Prudent in Arthritis Research & Therapy (2022)

  3. Article

    Open Access

    B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin

    B-lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) are members of the tumor necrosis factor (TNF) family that regulate B-cell maturation, survival, and function. They are overexpressed ...

    Stacey R Dillon, Brandon Harder, Kenneth B Lewis in Arthritis Research & Therapy (2010)

  4. No Access

    Article

    An APRIL to remember: novel TNF ligands as therapeutic targets

  5. TNF family members have a multitude of crucial roles in the immune response, and numerous companies have invested millions of dollars to develop therapeutic dr...

  6. Stacey R. Dillon, Jane A. Gross, Stephen M. Ansell in Nature Reviews Drug Discovery (2006)

  7. Article

    Erratum: Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

    Nature Immunology 5, 752–760 (2004). The published version of this article failed to include the microarray accession numbers. They are listed here: Geo microarray accession numbers. GSE1304, Control and Il31 ...

    Stacey R Dillon, Cindy Sprecher, Angela Hammond, Janine Bilsborough in Nature Immunology (2005)

  8. No Access

    Article

    Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

    T cell–derived cytokines are important in the development of an effective immune response, but when dysregulated they can promote disease. Here we identify a four-helix bundle cytokine we have called interleuk...

    Stacey R Dillon, Cindy Sprecher, Angela Hammond, Janine Bilsborough in Nature Immunology (2004)

  9. No Access

    Article

    Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

    Cytokines are important in the regulation of haematopoiesis and immune responses, and can influence lymphocyte development. Here we have identified a class I cytokine receptor that is selectively expressed in ...

    Julia Parrish-Novak, Stacey R. Dillon, Andrew Nelson, Angie Hammond in Nature (2000)

  10. No Access

    Article

    TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

    B cells are important in the development of autoimmune disorders by mechanisms involving disregulated polyclonal B-cell activation, production of pathogenic antibodies, and co-stimulation of autoreactive T cel...

    Jane A. Gross, Janet Johnston, Sherri Mudri, Rachel Enselman, Stacey R. Dillon in Nature (2000)